Keywords :
Brachytherapy; Chemotherapy, Adjuvant; Female; Humans; Neoplasm Staging; Radiotherapy Dosage; Uterine Cervical Neoplasms/diagnosis/therapy; Chemotherapy; Locally advanced; Radiotherapy; Cervical cancer
Abstract :
[en] Cervical cancer is the fourth most common cancer in women and is linked in over 95 % of cases to papillomavirus infection, the incidence of which has fallen in recent years due to screening and vaccination. Almost half of these cancers are diagnosed at a locally advanced stage with an overall 5-year survival of around 65 %. In recent decades, the management strategy of these locally advanced cancers has changed considerably and has allowed the improvement of survival but above all of local control as well as the reduction of toxicity, due to the implementation of imaging. Standard treatment consists of external beam radiation therapy combined with concomitant chemotherapy followed by intrauterine brachytherapy. The role of neo-adjuvant and adjuvant chemotherapy is still being evaluated. New therapeutic approaches (particularly immunotherapy) in addition to standard treatment are also being studied.
Scopus citations®
without self-citations
1